CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. VITRASE® AGREEMENTVitrase® Agreement • November 12th, 2004 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
THIS VITRASE® AGREEMENT (the “Agreement”) is effective as of September 27, 2004 (the “Effective Date”), by and among Allergan Sales, LLC., a Delaware Limited Liability Company (“ASLLC”) (formerly Allergan Sales, Inc., a California Corporation), Allergan Pharmaceuticals Ireland, a Cayman Islands Company, (“API”) (successor in interest to Allergan Sales Ltd., an Irish corporation) (ASLLC and API shall collectively be referred to as “Allergan”), and ISTA Pharmaceuticals, Inc., a Delaware corporation (“ISTA”).
